Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Blood Advances|August 23, 2021
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemiaLori Muffly, Vandana Sundaram, Connie Chen, et al.Blood|March 1, 2023
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agentsMichael A Spinner, R A Sica, John S Tamaresis, et al.Transplantation and Cellular Therapy|September 21, 2025
Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative StudyMarie-Michèle Sainvil, Ashley L Artese, Laura J Fish, et al.Transplantation and Cellular Therapy|January 18, 2022
Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center ReportAndriyana K Bankova, Joseph Caveney, Bin Yao, et al.Blood Advances|December 13, 2023
Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHDCameron S Bader, Anna Pavlova, Robert Lowsky, et al.Blood Advances|February 11, 2021
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphomaJohn H Baird, David J Epstein, John S Tamaresis, et al.Blood|June 22, 2021
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized studyMitchell E Horwitz, Patrick J Stiff, Corey Cutler, et al.Transplantation and Cellular Therapy|July 7, 2023
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell LymphomaNarendranath Epperla, Ambuj Kumar, Syed A Abutalib, et al.Journal for Immunotherapy of Cancer|July 2, 2024
Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphomaSushma Bharadwaj, Eric Lau, Mark P Hamilton, et al.The Journal of Experimental Medicine|June 20, 2020
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trialMatthew J Frank, Michael S Khodadoust, Debra K Czerwinski, et al.Pageof 7